title: Rivaroxaban: can we trust the evidence?
authors: Deborah
authors: D
authors: Cohen
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications; D002545:Brain Ischemia / Q000517:prevention & control*; D017277:Drug Approval; D004617:Embolism / Q000517:prevention & control; D005060:Europe; D019317:Evidence-Based Medicine / Q000592:standards*; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019934:International Normalized Ratio / Q000295:instrumentation / Q000592:standards; D000069552:Rivaroxaban / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D014859:Warfarin; D000069552:Rivaroxaban